Thursday, March 24, 2022 9:54:22 AM
Remember from the last Revive, Mf video interview he said 715.
Yea seen that in the F-book group lol..
Yep we wait little longer only good thing about that, I keep making my little buys for now for my Roth, but have my other a
rvvtf account also.
ps. Damn almost time to go to work... arhhh lol
PPs..
Yea seen that in the F-book group lol..
Yep we wait little longer only good thing about that, I keep making my little buys for now for my Roth, but have my other a
rvvtf account also.
ps. Damn almost time to go to work... arhhh lol
PPs..
@Revive_RVV pictured here in red. #bucillamine has been knocked by the #market but will eventually win against #COVID19 pic.twitter.com/4La8rVzmxA
— Revive Therapeutics (unofficial) (@revivethera) March 23, 2022
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
